Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $0.25.

  • Ironwood Pharmaceuticals' EPS (Basic) rose 115000.0% to $0.25 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.18, marking a year-over-year increase of 70000.0%. This contributed to the annual value of $0.01 for FY2024, which is 10015.5% up from last year.
  • As of Q3 2025, Ironwood Pharmaceuticals' EPS (Basic) stood at $0.25, which was up 115000.0% from $0.15 recorded in Q2 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' EPS (Basic) peaked at $2.42 during Q2 2021, and registered a low of -$6.84 during Q2 2023.
  • Over the past 5 years, Ironwood Pharmaceuticals' median EPS (Basic) value was $0.24 (recorded in 2022), while the average stood at -$0.1.
  • Its EPS (Basic) has fluctuated over the past 5 years, first crashed by 295000.0% in 2023, then soared by 160000.0% in 2025.
  • Ironwood Pharmaceuticals' EPS (Basic) (Quarter) stood at $0.25 in 2021, then grew by 28.0% to $0.32 in 2022, then crashed by 103.12% to -$0.01 in 2023, then surged by 200.0% to $0.01 in 2024, then surged by 2400.0% to $0.25 in 2025.
  • Its last three reported values are $0.25 in Q3 2025, $0.15 for Q2 2025, and -$0.23 during Q1 2025.